Recent Posts
- ASEAN Dengue Day: Island Pharmaceuticals Investor briefing video
- Are you ready for the 2022 Financial Year? What you need to know and trends to watch out for.
- Three takeaways from the 2021 AIRA conference
- Earned vs Bought media: Is it worth paying for a headline?
- No-Nonsense Guide to Building a Social Media Strategy
Archives
Categories
Tesserent presents at IRD Invest
On 14 October 2020, Tesserent CEO, Julian Challingsworth presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.
Jaxsta presents at IRD Invest
On 14 October 2020, Jaxsta CEO and co-founder, Jacqui Louez Schoorl and Jaxsta CFO, Company Secretary and Executive Director Jorge Nigaglioni, presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.
Openpay presents at IRD Invest
Openpay Group Ltd (ASX: OPY) is a well-established player in the fast-growing global market for ‘Buy now pay later’ (BNPL) payment solutions. Openpay partners with merchants to provide BNPL repayment plans to customers instore, in-app and online.
Oventus presents at IRD Invest
On 14 October 2020, Oventus CEO, Dr Chris Hart, presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.
Kazia achieves major milestones
Our client, ASX-listed oncology company Kazia Therapeutics Ltd (ASX: KZA; NASDAQ: KZIA, has had a huge few months, including the achievement of significant milestones for lead drug candidate, paxalisib.
- 1
